Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal | Orthopedics/Orthopedic Surgery
Disease Category: Ankylosing Spondylitis
Location: United States, MD
A randomized double blind placebo controlled dose ranging study to evaluate the efficacy and safety of IL-6Ra mAb in patients with Ankylosing Spondylitis
Do you have Ankylosing Spondylitis? You may qualify to participate in a clinical research study.
IL-6Ra mAb is a randomized placebo controlled trial of an injectable IL-6Rmab for patient with active sacroileitis from anklyosing spondylitis with active joint disease who are not responding to NSAIDs and are biologic agent naive. Prior DMARDs are allowed. There is 20 week treatment period.
The Center for Rheumatology and Bone Research
2730 University Blvd West, Suite 306
Wheaton, MD 20902
Phone: 301 942-6610
Fax: 301 942-7833
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these